Author Archives: Jan Paschal

Phase I biotech CAMP4 Therapeutics (CAMP) took the road less traveled on its way to going public. CAMP4 Therapeutics Corp. priced its IPO at $11.00 – $3 below the bottom of its $14.00-to-$16.00 price range – and increased the IPO’s size at pricing – to 6.82 million shares – up from 5.0 million shares in […]

More stock, priced at the top of its range: Phase II biotech UpStream Bio (UPB) upsized its IPO at pricing to 15.0 million shares – up from 12.5 million in the prospectus – and priced the deal at $17.00 – the top of its $15.00-to-$17.00 range – to raise $255.0 million on Thursday night, Oct. 10, […]

CeriBell (CBLL Proposed), the maker of an AI-assisted medical device system to monitor critically ill patients at risk for seizures, increased its IPO’s size by 74 percent to raise $175 million in an SEC filing early today, Wednesday, Oct. 9, 2024. CeriBell now is offering 10.61 million shares (10,606,060 shares) – up from 6.7 million […]

Someone at KinderCare (KLC) must like the sight and sound of 24: KinderCare priced its IPO at $24 – $1 above the low end of its $23-to-$27 range – and sold 24.0 million shares – the number of shares in the prospectus – to raise $576 million on Tuesday night, Oct. 8, 2024. At pricing, KinderCare’s […]

SKK Holdings Limited (SKK), the holding company of a  Singapore civil engineering services provider, priced its micro-cap IPO at $4.00 – the low end of its $4.00-to-$5.00 price range – today, Monday, Oct. 7, 2024. SKK Holdings Limited sold 2.5 million shares – the number of shares in the prospectus – at $4.00 each – […]

KinderCare Learning Companies, Inc. (KLC Proposed), a chain of U.S. early childhood education centers, and Moove Lubricants Holdings (MOOV Proposed), a Brazilian industrial lubricants company, are leading this week’s IPO Calendar of about $1.4 billion in deals. The IPO  Calendar expanded early today – Monday, Oct. 7, 2024 – with the addition of three deals […]

UpStream Bio (UPB Proposed) unveiled the terms and launched its $200 million IPO early today – Monday, Oct. 7, 2024. The Phase II biotech, whose leading drug candidate is targeting severe asthma, chronic rhinosinusitis with nasal polyps, and COPD, is offering 12.5 million shares at a price range of $15.00 to $17.00 to raise $200 […]

BingEx Ltd  (FLX) priced its IPO at $16.50 – just above the mid-point of its $15.00-to-$17.00 price range – and sold 4.0 million American Depositary Shares (ADS) – the number in the prospectus – to raise $66.0 million on Thursday night, Oct. 3, 2024. The ADS opened flat – at $16.50 – on NASDAQ at 10:57 […]

Chain Bridge Bancorp (CBNA), a banking company that caters to the Republican Party’s PACs and campaign fundraising entities, priced its IPO at $22.00 – $2.00 below the bottom of its $24.00-to-$26.00 price range – on Thursday night, Oct. 3, 2024. The McLean, Virginia-based bank holding company sold 1.85 million shares – the number of shares […]

StandardAero (SARO) took off in its NYSE debut today. Shares of StandardAero shot up to open  at $31.00 –  up $7.00 for a 29.2 percent gain from their IPO price of $24.00 – when they started trading at midday on Wednesday, Oct. 2, 2024, on the New York Stock Exchange. That strong opening gave StandardAero a market […]